{
  "nct_id": "NCT49508147",
  "indication": "Psoriasis",
  "phase": "Phase 2",
  "sample_size": 354,
  "duration_weeks": 54,
  "dropout_rate": 0.33,
  "primary_endpoints": [
    "Quality of life improvement"
  ],
  "secondary_endpoints": [
    "PASI 75 response",
    "IGA score"
  ],
  "blinding": "double-blind",
  "control_arm": "placebo",
  "outcome_summary": "Study did not demonstrate sufficient efficacy.",
  "success": false,
  "failure_reason": "Poor recruitment/enrollment"
}